MetaCap

Cigna Group (CI) vs Illumina (ILMN)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Illumina (ILMN) has outperformed Cigna Group (CI) over the past year, gaining 55.7% versus a loss of 2.6%. Over five years, CI leads with a +34.1% price change compared with -46.4% for ILMN. Cigna Group is the larger company by market cap ($71.38 billion vs $29.15 billion), about 2.4 times the size.

On valuation, Cigna Group trades at a lower forward P/E (8.1x vs 31.2x for Illumina). Cigna Group pays a dividend yielding 2.28%, while Illumina does not currently pay one. Illumina converts more of its revenue into profit, with a net margin of 19.6% versus 2.2%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CI-2.59%ILMN+55.69%
+144%+65%-15%
Nov 21, 20251 yearNov 20, 2026
CI+28.69%ILMN-47.75%
+81%-4%-88%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CI versus ILMN key metrics
MetricCIILMN
Share price$270.90$192.82
Market cap$71.38B$29.15B
1-day change-0.78%-3.90%
YTD return-1.57%+47.01%
1-year return-2.59%+55.69%
5-year return+34.09%-46.40%
P/E ratio (TTM)11.9433.19
Forward P/E8.1431.19
EPS (TTM)$22.68$5.81
Dividend yield2.28%0.00%
Annual dividend$6.19$0.00
Revenue (latest FY)$274.90B$4.34B
Revenue growth (YoY)+11.24%-0.66%
Net income (latest FY)$5.96B$850.00M
Gross margin21.79%66.08%
Operating margin3.35%18.58%
Net margin2.17%19.57%
52-week high$318.05$309.35
52-week low$257.85$112.65
Distance from 52-week high-14.82%-37.67%
Analyst consensusbuybuy
Avg. price target upside+27.13%+35.59%
Average volume1.66M2.82M
Shares outstanding263.50M151.20M
Employees65,6698,600
SectorHealth CareHealth Care
IndustryMedical SpecialitiesMedical Specialities

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Cigna Group is about 2.4 times larger than Illumina by market value ($71.38B vs $29.15B).
  • ILMN has outperformed CI by 58.3 percentage points over the past year.
  • Illumina trades at a higher earnings multiple (33.2x vs 11.9x trailing P/E).
  • Cigna Group offers a meaningfully higher dividend yield (2.28% vs 0.00%).
  • Illumina is more profitable, keeping 19.6 cents of every revenue dollar as net income versus 2.2 cents for Cigna Group.
  • Cigna Group grew revenue faster in its latest fiscal year (+11.24% vs -0.66%).

About Cigna Group

CI stock →

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare.

Health Care · Medical Specialities · 65,669 employees

About Illumina

ILMN stock →

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Health Care · Medical Specialities · 8,600 employees

CI vs ILMN FAQ

Which is bigger, Cigna Group or Illumina?

Cigna Group (CI) is larger, with a market capitalization of $71.38B compared with $29.15B for Illumina (ILMN).

Which stock has performed better over the past year, CI or ILMN?

ILMN returned +55.69% over the past 12 months, compared with -2.59% for CI (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, CI or ILMN?

CI has the lower trailing P/E at 11.9, versus 33.2 for ILMN. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, Cigna Group or Illumina?

Cigna Group pays a dividend yielding 2.28%, while Illumina does not currently pay a regular dividend.

Are Cigna Group and Illumina in the same industry?

Yes. Both are classified in the Medical Specialities industry within the Health Care sector.

More comparisons